Why You’re Not Ovulating With PCOS (and What Can Help)

Your period arrived, so you must have ovulated. It’s what most of us assume, and with PCOS it isn’t always true. Maybe your cycles stretch to 45 days or skip whole months. Maybe you’ve spent weeks with ovulation strips and still can’t tell what your body is doing. Or maybe your periods arrive on schedule, and you wonder whether an egg is being released at all.

Understanding why you’re not ovulating with PCOS matters even when pregnancy isn’t on your mind. Ovulation is the main way your body makes progesterone, a hormone that steadies the second half of your cycle and keeps your uterine lining in balance. Here’s how ovulation works, what disrupts it in PCOS, how to tell whether it’s happening, and which treatments are worth discussing with a clinician.

A quick note on names: in May 2026, PCOS was officially renamed polyendocrine metabolic ovarian syndrome (PMOS), and both names will be used for about three years. We’ll say PCOS here because it’s still what most people search for.

How ovulation works, and what happens afterward

A cycle in plain language

Every cycle begins on the first day of your period. Your brain releases follicle-stimulating hormone (FSH), which encourages a group of follicles in your ovaries to grow. Follicles are tiny fluid-filled sacs, each holding an immature egg, and they make estrogen, which rebuilds your uterine lining. Usually one pulls ahead and becomes the dominant follicle.

When estrogen climbs high enough, your brain responds with a burst of luteinizing hormone (LH). That LH surge triggers ovulation, the moment the dominant follicle releases its egg, as a StatPearls overview of ovulation describes.

What the follicle leaves behind becomes a temporary gland called the corpus luteum, which makes progesterone. Progesterone matures the uterine lining and keeps the second half of your cycle steady. The second half is fairly consistent, about 14 days from ovulation to your next period, while the first half varies more. If there’s no pregnancy, the corpus luteum fades, progesterone drops, and the lining sheds. Typical cycles run 21 to 35 days.

Why a period isn’t proof of ovulation

This is where PCOS gets confusing, because bleeding doesn’t require ovulation. Without it there’s no corpus luteum and no progesterone, so estrogen keeps building the lining with nothing to balance it, which clinicians call unopposed estrogen. Eventually the lining outgrows its support and sheds. It looks like a period, but it isn’t the progesterone-driven kind that follows ovulation, as StatPearls explains in its overview of anovulatory bleeding.

Why PCOS can disrupt ovulation

The link between PCOS and ovulation starts inside the ovary. Anovulation, meaning no egg is released in a cycle, is the main reason periods become irregular in PCOS, and the clearest finding is that many follicles start to grow but stall at a small size, with none selected to mature. On ultrasound, those paused follicles give the ovaries the “polycystic” look the name refers to. Researchers describe this arrest of follicle growth as the characteristic feature of anovulation in PCOS.

Why the follicles stall isn’t fully settled, but several influences appear to work together:

• LH and FSH signalling. Follicles need FSH to mature, and one has to be selected as dominant. In PCOS, LH is often elevated, and together with high insulin this appears to push FSH relatively low, so the signal is too weak for any follicle to be chosen. That’s only part of the picture: LH and FSH levels aren’t used to diagnose PCOS, and local signals inside the ovary, including anti-Müllerian hormone (AMH), a hormone made by small follicles, appear to matter too. Raising FSH can restart growth, which is how injectable fertility treatments work.
• Excess androgens. Androgens, such as testosterone, are made in small amounts by every ovary, but in PCOS there’s more. One leading explanation is that this excess inside the ovary is the main culprit behind the stalled follicles. We look at where it comes from in our article on PCOS and high testosterone.
• Insulin. Many women with PCOS have insulin resistance, meaning cells respond poorly to insulin, so the body makes extra. That extra insulin appears to amplify the ovary’s androgen production and worsen the stall, as we explain in our article on insulin resistance and PCOS.

The pieces are well described, but how they fit together, and what sets the process off, is still debated. Some researchers think abnormalities begin in the earliest stages of follicle development, which is one reason treatments can’t yet target a single cause.

It’s also why PCOS looks different from person to person. In adults, the international guideline requires two of three features once other causes have been ruled out: high androgens (on examination or blood tests), ovulatory dysfunction, and polycystic ovaries on ultrasound or a raised AMH level. AMH tends to run higher when many small follicles are present, so it can stand in for ultrasound, but it shouldn’t be the only test used for diagnosis, and it isn’t needed when irregular cycles and high androgens are already present. It also varies with age, can be lowered by hormonal contraception, and has no universal cut-off, as ASRM notes. (Criteria differ in adolescents.) Because only two of the three are required, the answer to “can you ovulate with PCOS?” is yes: some women ovulate rarely, some occasionally, and some regularly.

One clarification: low progesterone in PCOS is usually a result of not ovulating, not the cause. No ovulation means no corpus luteum, and no corpus luteum means very little progesterone.

Signs you might not be ovulating with PCOS

PCOS irregular periods are the strongest clue. The guideline defines irregular cycles in adults as cycles shorter than 21 days or longer than 35, fewer than eight a year, or any gap longer than 90 days. The American Society for Reproductive Medicine (ASRM) goes further: a history of infrequent or absent periods is, by itself, enough to establish that ovulation isn’t happening regularly.

Ovulation strips and PCOS

Ovulation predictor kits detect the LH surge in urine. They’re designed for typical cycles, and women with PCOS can have persistently high baseline LH, which can cause false positives, as ASRM notes. Irregular cycles also make it easy to miss a surge. And even a correct positive is only indirect evidence of ovulation, not proof that an egg was released.

Cervical mucus and temperature

Cervical mucus changes as estrogen rises before ovulation, but because it follows estrogen rather than ovulation itself, it can’t confirm an egg was released, as a review of ovulation detection methods explains. Basal body temperature (your resting temperature first thing in the morning) rises slightly after ovulation because of progesterone, but only in hindsight, and it’s often unreliable. ASRM doesn’t routinely recommend it, and NICE’s 2026 fertility guideline advises against using temperature charts to confirm ovulation.

Progesterone blood tests and timing

The most direct everyday test is a blood progesterone measured in the second half of the cycle, after ovulation would have happened. It isn’t automatically a cycle day 21 test: ASRM advises drawing it about a week before your expected period, because cycle lengths vary. If your cycles are long or unpredictable, that timing is hard to know, so NICE suggests testing later in the cycle and repeating weekly until your period starts. One result can confirm recent ovulation, but not how healthy the luteal phase was.

Because each method is imperfect, a single negative strip or a missing symptom can’t settle the question. What matters is the pattern, and a clinician can help you read it.

Can you have regular periods and still not ovulate?

Yes, though it’s less common. Regular cycles usually do point to ovulation: ASRM notes that ovulation is very likely when cycles are regular (25 to 35 days, in its definition) and there’s no excess hair growth. The picture changes when there is. In women with regular periods and excess hair growth, a sign of high androgens, ASRM puts regular ovulation at roughly 60%, and the PCOS guideline likewise notes that ovulatory dysfunction can occur with regular cycles. If you’re unsure, ASRM suggests considering a progesterone test about a week before your expected period, sometimes alongside an ultrasound.

What can help restore or support ovulation with PCOS?

Two different goals use different tools. Some treatments manage PCOS and regulate bleeding, while others trigger ovulation, usually because someone wants to conceive. Which applies to you shapes the rest.

Lifestyle, insulin resistance, and weight when relevant

The guideline recommends healthy lifestyle habits for everyone with PCOS, notes they bring benefits even without weight loss, and doesn’t name one best diet or exercise routine. A September 2026 review in PLOS Medicine found lifestyle programs were linked to higher odds of regular cycles, but only five small studies measured it, many trials had weaknesses, and no single approach came out on top. Regular cycles also aren’t confirmed ovulation, so this is encouraging but unproven. Weight management can bring clinical improvements for women with higher weight, though not every woman with PCOS needs to lose weight. Our PCOS diet article covers eating habits that support insulin sensitivity.

Metformin

Metformin is a diabetes medicine that helps cells respond better to insulin. The guideline recommends it mainly for metabolic features, with irregular cycles an option when the pill isn’t suitable. In trials, it increased ovulation and menstrual frequency compared with placebo, though the Cochrane review rated the evidence for live birth as low quality, and metformin caused more stomach side effects. It also appears less effective than clomiphene at inducing ovulation in women with higher weight.

Inositol

Inositol is a popular PCOS supplement. The guideline says it could be considered based on personal preference, with limited harm, but notes limited clinical benefits including for ovulation. For fertility, it classes inositol as experimental, with benefits and risks too uncertain to recommend, and products vary in dose and quality. If you take it, tell your clinician. Our inositol article covers the research.

Letrozole and other treatments to induce ovulation

For women who want to conceive, the guideline names letrozole, an oral medicine, as the first-line treatment for inducing ovulation when there’s no other fertility factor. In a trial of 750 women, it led to more live births than clomiphene, about 27.5% versus 19.1% over up to five treatment cycles, with higher ovulation rates. It’s used off-label in many countries and needs medical supervision. Pregnancy should be ruled out before starting, since the guideline says letrozole shouldn’t be given if there’s any possibility of an existing pregnancy, though it found no evidence of more birth defects than with other ovulation-induction medicines.

If it doesn’t work, second-line options include clomiphene alone or with metformin, injectable gonadotrophins (which need ultrasound monitoring because of multiple-pregnancy risk), and laparoscopic ovarian surgery, with IVF third. The guideline stresses that pregnancy can often be achieved naturally or with assistance.

Birth control pills and cyclic progestogens: managing the cycle, not restoring ovulation

The combined pill is the guideline’s first-line option for irregular cycles and high-androgen features when you’re not trying to conceive. It works mainly by preventing ovulation, so the monthly bleed on it is a withdrawal bleed from the hormone-free week, not a sign you’ve started ovulating. Progestogen-only options may be used to protect the uterine lining, though the guideline notes evidence in PCOS is limited. Both are useful, but they solve a different problem than ovulation.

When to see a doctor

Get evaluated if your periods fit the irregular pattern described above, if they’ve stopped, or if you’re trying to conceive; ASRM advises starting fertility testing without delay when cycles are irregular or absent, rather than waiting a year. If a period is late, take a pregnancy test first.

PCOS isn’t the only possible explanation. The guideline recommends checking thyroid function, prolactin, and 17-hydroxyprogesterone (for non-classic congenital adrenal hyperplasia, a milder, inherited adrenal condition) before diagnosing PCOS. Absent periods can call for further evaluation, including problems with the brain’s signalling to the ovaries, and ASRM lists weight changes, intense exercise, and perimenopause among other causes.

Very infrequent periods also matter for your uterine lining. When ovulation is rare, the lining can build up for long stretches without shedding. The guideline notes that women with PCOS have a markedly higher risk of endometrial hyperplasia (overgrowth of the lining) and endometrial cancer, while stressing that the overall chance of cancer is low and routine screening isn’t recommended. Long-standing untreated absent periods add to the risk, and protective strategies include regular cycles, regular progestogen therapy, and weight management where relevant.

What to take from all this

PCOS can interrupt ovulation because follicles start to grow and then stall, driven by several interacting signals, including LH and FSH, androgens, and insulin. A period, an ovulation strip, mucus, and temperature each tell only part of the story, so a well-timed progesterone test and a clinician’s reading of your pattern outweigh any single clue.

If you’re not trying to conceive, the useful conversation is usually about cycle management, protecting your uterine lining, and your metabolic health. If you are, letrozole and the other options above are well studied and worth raising early.

This article is for general education and does not replace advice from a qualified healthcare provider.

References

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463. Monash University guideline summary: https://www.monash.edu/__data/assets/pdf_file/0003/3371133/PCOS-Guideline-Summary-2023.pdf. Terminology update (June 2026): https://www.monash.edu/medicine/mchri/pcos/guideline
2. Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: new name to improve diagnosis and care of condition affecting 170 million women worldwide. Press release, 12 May 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
3. Physiology, ovulation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. https://pubmed.ncbi.nlm.nih.gov/28723025/
4. Physiology, follicular phase. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK542229/
5. Anovulatory bleeding. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549773/
6. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367-378. https://pubmed.ncbi.nlm.nih.gov/18499708/
7. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107-117. https://academic.oup.com/humupd/article/10/2/107/617160
8. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2026 (replaces the 2021 version, Fertil Steril 2021;116:1255-1265). https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
9. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment (NG257). Published 31 March 2026. https://www.nice.org.uk/guidance/ng257/chapter/Investigation-of-fertility-problems-and-management-strategies
10. Su HW, Yi YC, Wei TY, Chang TC, Cheng CM. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017;2(3):238-246. doi:10.1002/btm2.10058
11. Olalere O, Koh MD, Crabb K, et al. The effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis. PLoS Med. 2026;23(9):e1004887. doi:10.1371/journal.pmed.1004887
12. Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11:CD003053. doi:10.1002/14651858.CD003053.pub6. https://pubmed.ncbi.nlm.nih.gov/29183107/
13. Sharpe A, Morley LC, Tang T, Norman RJ, Balen AH. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;12:CD013505. doi:10.1002/14651858.CD013505. https://pmc.ncbi.nlm.nih.gov/articles/PMC6915832
14. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119-129. doi:10.1056/NEJMoa1313517
15. Cooper DB, Mahdy H. Oral contraceptive pills. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430882/
16. Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329-2339. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext